Metraipolis › archive › dc_e2a3592cb6e2

The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells — Europe PMC PMID:39796712

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39796712
DOI
10.3390/cancers17010081
License (as archived)
solo-consultazione
Archived
2026-10-08T06:34:56.029Z
SHA-256 of the archived text
6b814e27bea909a5189b6d2d0f715137ff21e28aaac608c66ed6f6d4d6d826fd
Stable URL of this page
https://metraipolis.com/documento/dc_e2a3592cb6e2

How to cite

The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells — Europe PMC PMID:39796712 — Europe PMC (en), https://europepmc.org/article/MED/39796712 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2a3592cb6e2 (Metraipolis archive dc_e2a3592cb6e2, sha256 6b814e27bea909a5189b6d2d0f715137ff21e28aaac608c66ed6f6d4d6d826fd)
BibTeX
@misc{dce2a3592cb6e2,
  title = {The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells — Europe PMC PMID:39796712},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39796712},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2a3592cb6e2; sha256 6b814e27bea909a5189b6d2d0f715137ff21e28aaac608c66ed6f6d4d6d826fd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39796712. Agents can read the archived copy with the MCP tool read_document.